Ustekinumab levels correlate with induction fecal calprotectin drop-slope and discriminate the need for intensification at week 52 in Crohn's Disease patients

被引：1
|
作者：
Mateos, B. [1 ]
Saez-Gonzalez, E. [2 ]
Iborra, M. [2 ]
Moret, I. [1 ]
Canada, A. [3 ]
Tortosa, L. [1 ]
Bastida, G. [2 ]
Aguas, M. [2 ]
Cerrillo, E. [2 ]
Nos, P. [2 ]
Beltran, B. [2 ]
机构：
[1] Hlth Res Inst La Fe, Inflammatory Bowel Dis, Valencia, Spain
[2] La Fe Hosp, Gastroenterol, Valencia, Spain
[3] Hlth Res Inst La Fe, Biostat, Valencia, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.697
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P576
引用
收藏
页码：S533 / S534
页数：3
相关论文
共 45 条
  • [1] USTEKINUMAB LEVELS DEPEND ON INDUCTION FECAL CALPROTECTIN DROP-SLOPE AND CAN DISCRIMINATE THE NEED OF INTENSIFICATION AT WEEK 52 IN CROHN'S DISEASE PATIENTS
    Mateos, Beatriz
    Saez-Gonzalez, Esteban
    Iborra, Marisa
    Moret, Ines
    Canada, Antonio
    Tortosa, Luis
    Bastida, Guillermo
    Aguas, Mariam
    Cerrillo, Elena
    Nos, Pilar
    Beltran, Belen
    GASTROENTEROLOGY, 2021, 160 (06) : S694 - S694
  • [2] Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease
    Pauwels, Renske W. M.
    Huinink, S. Ten Bokkel
    van der Woude, Christien J.
    Doukas, M.
    Oudijk, L.
    de Vries, Annemarie C.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (09) : 980 - 987
  • [3] ARE LOWER LEVELS OF FECAL CALPROTECTIN REASSURING IN CROHN'S DISEASE PATIENTS?
    Monteiro, Sara
    de Castro, Francisca Dias
    Leite, Silvia
    Moreira, Maria Joao
    Cotter, Jose
    GASTROENTEROLOGY, 2018, 154 (06) : S391 - S391
  • [4] Levels of Fecal Calprotectin and the Severity of Postoperative Patients With Crohn's Disease
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (08): : 1241 - 1242
  • [5] Levels of Fecal Calprotectin and the Severity of Postoperative Patients With Crohn's Disease Response
    Boschetti, Gilles
    Drai, Jocelyne
    Flourie, Bernard
    Nancey, Stephane
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (08): : 1242 - 1242
  • [6] Ustekinumab Dose Intensification Can Be Effective in Crohn's Disease Patients Not Responding to Induction
    Young, Ari
    Tsistrakis, Steven
    Rubinov, Jason
    Kohan, Elizabeth
    Hirten, Robert
    Ungaro, Ryan
    Cohen, Benjamin
    Cho, Judy
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Oikonomou, Ioannis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S350 - S351
  • [7] Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
    Beltran, Belen
    Iborra, Marisa
    Saez-Gonzalez, Esteban
    Marques-Minana, Maria R.
    Moret, Ines
    Cerrillo, Elena
    Tortosa, Luis
    Bastida, Guillermo
    Hinojosa, Joaquin
    Luis Poveda-Andres, Jose
    Nos, Pilar
    DIGESTIVE DISEASES, 2019, 37 (02) : 108 - 115
  • [8] Ustekinumab Dose Intensification in Patients With Crohn's Disease: Comparing Every 4 and Every 6-Week Dosing
    Dalal, Rahul S.
    Njie, Cheikh
    Sanchit, Gupta
    Allegretti, Jessica R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S414 - S414
  • [9] Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease
    Boschetti, Gilles
    Laidet, Marc'harid
    Moussata, Driffa
    Stefanescu, Carmen
    Roblin, Xavier
    Phelip, Gildas
    Cotte, Eddy
    Passot, Guillaume
    Francois, Yves
    Drai, Jocelyne
    del Tedesco, Emilie
    Bouhnik, Yoram
    Flourie, Bernard
    Nancey, Stephane
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (06): : 865 - 872
  • [10] Serial measurements of fecal calprotectin help discriminate intestinal tuberculosis and Crohn's disease in patients started on antitubercular therapy trial
    Sharma, Vishal
    Varma, Suhang
    Kumar-M, Praveen
    Mandavdhare, Harshal S.
    Singh, Harjeet
    Shah, Jimil
    Kalsi, Dimple
    Dutta, Amitava
    Mishra, Shubhra
    Prasad, Kaushal K.
    Sharma, Arun K.
    Dutta, Usha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 534 - 534
12345